Roswell Park Comprehensive Cancer Center and Moffitt Cancer Center have partnered with more than 50 other cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose CT scans for those at high risk for lung cancer.
Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer.
Sanford Burnham Prebys has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.
A study of 50 adult patients with cystic fibrosis (CF) has found that challenged urine bicarbonate excretion may offer a new, simple, and safe quantification of cystic fibrosis transmembrane conductance regulator (CFTR) function and the extent of its pharmacologic improvement. The study is published in Annals of Internal Medicine.
According to the American Lung Association, Black Americans, Latinos, Asian Americans or Pacific Islanders and Indigenous people who are diagnosed with lung cancer face worse outcomes compared to white Americans because they are less likely to be diagnosed early. Rutgers Cancer Institute expert shares how these disparities are being addressed and where to find cancer screening resources.
According to the 2021-2023 edition of the American Cancer Society’s Cancer Facts and Figures for Hispanic/Latino People, about 6,000 Hispanic men and 5,800 Hispanic women are expected to be diagnosed with cancer of the lung and 3,200 Hispanic men and 2,300 Hispanic women are expected to die from the disease this year. Expert from Rutgers Cancer Institute shares what the Hispanic community needs to know about the disease.
In a new study with obese mice, Johns Hopkins Medicine researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people.
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.
Invitation for emergency medicine symposium
A new study investigated the expression of the primary cilium in mesothelioma, finding that primary cilia is preferentially lost in the more aggressive subtype of mesothelioma and further research may confirm its potential prognostic and diagnostic value.
George Alba, MD, of Massachusetts General Hospital/Harvard has been named the inaugural American Thoracic Society/American Lung Association/American College of Chest Physicians-Harold Amos Medical Faculty Development Program Scholar.
Researchers at the University of Illinois College of Veterinary Medicine have demonstrated in a mouse model that a specific type of T cell, one of the body’s potent immune defenses, produces cytokines that are necessary for the body to acquire immunity against fungal pathogens.
Cedars-Sinai and other hospitals nationwide are seeing a surge in cases of pediatric RSV (respiratory syncytial virus) that are showing up earlier than expected this year. Healthcare providers are worried about the onset of the virus combined with the additional threats of the flu and COVID-19 as we head into winter.
The American Society of Anesthesiologists (ASA) today presented David O. Warner, M.D., with its 2022 Excellence in Research Award in recognition of his extensive research efforts to help improve patient care before, during and after surgery.
The latest articles that have been added to the Environmental Health channel.
A new multi-disciplinary study including researchers at the University of Calgary shows that people who act quickly to test for and mitigate radon gas in their homes are at a much lower risk of developing lung cancer long-term.
Investigators from the departments of Neurology, Neurosurgery, Psychiatry, Medicine, and Biomedical Sciences at Cedars-Sinai have shown that an immune-suppressing drug similar to one used to treat severe COVID-19 reversed symptoms of delirium in mice whose lungs were injured during mechanical breathing assistance.
.jpg&width=400&height=400)
The study was done for the World Health Organization (WHO) and Canadian Institutes of Health Research testing accessibility to recommendations for tuberculosis, a preventable and curable disease which is still the world’s top infectious killer. Researchers found the new approach is much more accessible, people are more satisfied and the new presentation improved the understanding of the information.
NIH’s National Institute of Allergy and Infectious Diseases awarded Texas Biomedical Research Institute and The Access to Advanced Health Institute in Seattle, Washington, a $3.5 million, five-year Innovation for Tuberculosis Vaccine Discovery grant.
Antonia “Toni” Perez is one in a million. She’s one of 1 million patients in the U.S. who have received an organ transplant, a milestone the nation celebrated last month.
People living with HIV must be included in clinical trials for new tuberculosis vaccine candidates currently in the development pipeline, say experts on an international panel convened last year to address gaps in the current TB vaccine landscape. Their recommendations appear in a new paper published today in The Lancet HIV.
Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors are potentially related to adverse events in patients with metastatic Non-Small-Cell-Lung Cancer (mNSCLC).
Flu season is here. Rutgers Cancer Institute expert shares what cancer patients and their families need to know.
UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.
A cohort study of more than one million people has found that most persons screened for lung cancer meet U.S. Preventative Services Task Force (USPSTF) criteria, but men, persons who formerly smoked, and younger eligible patients are less likely to be screened. Adherence to follow-up screening was also poor. The findings are published in Annals of Internal Medicine.
Researchers have identified the gene TDRD7 as a key regulator against influenza A virus (IAV), which causes respiratory tract infections in 5 to 20 percent of the human population.
A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the ”la Caixa” Foundation, has found that exposure to phthalates in the womb is associated with reduced lung function during childhood.
肺癌是全球癌症死亡的主要原因。据世界卫生组织报告，全球每年约有180万人死于肺癌，约两倍于第二大致死癌症结肠直肠癌的每年报告死亡人数。 但有多项设计良好的权威研究显示，组织得当的筛查计划可将肺癌死亡人数降低20%。 筛查计划旨在及早发现肺癌，因为早期肺癌的治疗成功率更高。一般建议肺癌高风险人群接受筛查。高风险人群通常包括像您这样在人生某个阶段大量吸烟的人。
O câncer de pulmão é a principal causa de mortes por câncer no mundo todo. Cerca de 1,8 milhão de pessoas morrem anualmente de câncer de pulmão no mundo todo, quase o dobro de vidas perdidas a cada ano em relação à segunda causa de mortes, o câncer colorretal, s segundo a Organização Mundial da Saúde.
الإجابة: سرطان الرئة هو السبب الرئيسي للوفاة بالسرطان حول العالم. حوالي 1.8 مليون شخصٍ يموتون سنويًا بسبب سرطان الرئة حول العالم، أكثر من ضعف العدد الحالات مقارنةً بالسبب الثاني للوفاة بالسرطان سنويًا، سرطان القولون والمستقيم، وفقًا لمنظمة الصحة العالمية.
El cáncer de pulmón es la principal causa de muerte por cáncer en todo el mundo, ya que alrededor de 1,8 millones de personas mueren anualmente debido a este tipo de cáncer lo que corresponde aproximadamente al doble de la cantidad de vidas perdidas debido al cáncer colorrectal que es la segunda causa de muerte por cáncer, según datos de la Organización Mundial de la Salud.
The American Thoracic Society recognizes race is a social construct, not a clinical or biologic construct, and is committed to reducing health disparities and addressing racism in clinical decision-making in medicine.
A short-term quality improvement initiative at Nebraska Medicine quickly reduced the incidence of facial pressure injuries and led to institution-wide adoption of different types of noninvasive oxygen delivery devices.
Fungal diseases in the human population are on the rise, so it is important for health authorities to understand where these pathogens come from.
The Centers for Disease Control and Prevention (CDC) has issued a health advisory about an increase in children being hospitalized with severe respiratory illness who also tested positive for the rhinovirus or enterovirus EV-D68. That particular enterovirus has been associated with acute flaccid myelitis (AFM) – a rare polio-like illness that affects the nerve cells in the gray matter of the spinal cord and could lead to permanent paralysis.
UC San Diego engineers have developed microscopic robots, called microrobots, that can swim around in the lungs, deliver medication and be used to clear up life-threatening cases of bacterial pneumonia. In mice, the microrobots safely eliminated pneumonia-causing bacteria in the lungs and resulted in 100% survival. By contrast, untreated mice all died within three days after infection.
A new service at Children’s Hospital Los Angeles is providing comprehensive care for children with a debilitating post-COVID condition. Some teens can’t get back to the sports they love. Other children can no longer get through a school day—or even walk up a flight of stairs. Still others feel “off”—and anxious and depressed, too.
On World Lung Day, Sept. 25, 2022, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, calls on governments worldwide to address stark global inequalities in respiratory health.
Pascack Valley Medical Center received recertification of its Cardiac and Pulmonary Rehabilitation programs from the American Association of Cardiovascular and Pulmonary Rehabilitation. The certification recognizes the hospital for commitment to improving patient outcomes and quality of life by enhancing standards of care.
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has awarded Jonathan Backer, M.D., professor and chair of molecular pharmacology at Albert Einstein College of Medicine and associate director for shared resources at Montefiore Einstein Cancer Center (MECC), a five-year, $10 million team science (P01) grant to investigate the mechanisms regulating cancer cells that seed tumors in the lungs, a key metastatic site for breast cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
